©1996-2019. All Rights
Reserved. Online Journal of Bioinformatics . You
may not store these pages in any form except for your own personal use. All
other usage or distribution is illegal under international copyright treaties.
Permission to use any of these pages in any other way besides the before mentioned
must be gained in writing from the publisher. This article is exclusively
copyrighted in its entirety to OJB publications. This article may be copied
once but may not be, reproduced or re-transmitted
without the express permission of the editors. This
journal satisfies the refereeing requirements (DEST) for the Higher Education
Research Data Collection (Australia). Linking: To link to this page or any pages linking
to this page you must link directly to this page only here rather than put up
your own page.
OJBTM
Online Journal of
Bioinformatics ©
Volume 15 (1): 1-34, 2014.
A novel
strategy of In silico peptide vaccine design for Streptococcus
mutans.
Brittany
Bower and Anton Dormer MD MS.*
Washington Adventist University,
7600 Flower Avenue, Takoma Park, Maryland 20912 (301) 891-4229, USA
*Corresponding author
ABSTRACT
Bower B,
Dormer A., A novel In silico peptide vaccine design for Streptococcus mutans, Onl J Bioinform 15(1):1-34, 2014. Several attempts have been made towards the
development of a viable vaccine for Streptococcus
mutans (S. Mutans). This Gram positive bacterium is found within
the oral cavity of humans and is a main inducer of dental caries. The objective of this study is to identify
potential peptide vaccine candidates targeted to treat a primary cause of
dental caries. The hypothesis is that through the use of In silico tools, T-cell restricted epitopes targeted to S. Mutans can
be recognized as potentials for therapeutic development. The novel approach adapted for this
study includes the use of predicted algorithms, QSAR, and protein fold level
simulation analysis in order to identify B-cell and T-cell peptide vaccine
candidates from S. Mutans
glucosyltransferase D (GtfD) protein structure: a key
enzyme dental caries pathogenesis. One B-cell (EDDKAASESSQTDAPKTKQA) (20-mer)
and five B-cell epitope originated T-cell restricted epitopes to MHC Class I
HLA-A*0201 (GQDMKITYV)(9-mer), -A*0204 (QIDGKYYYI)(9-mer), -B*2705
(KRYFDDGSG)(9-mer), and MHC Class II HLA-DRB1*0101 (NNWYYFGSDGVAVTG)(15-mer),
and -DRB1*0401 (KIETKISQTQQTQWL)(15-mer) were identified. The MHC Class I and
Class II restricted peptides predicted in this study would stimulate
T-cytotoxic (CD8+) and T-helper (CD4+) lymphocytes, respectively. This design
could be used to stimulate CD8+, CD4+, and B-cells, all aspects of the adaptive
immune system. Therefore, these restricted epitopes are designed to induce both
a humoral and cellular immunological responses for use in a multi-valent
vaccine. As with all epitopes selected by In silico tools In Vitro and In Vivo experimental verification will
be the next step.
KEYWORDS: S.
Mutans, dental caries, vaccine, enzyme GtfD.
FULL-TEXT (SUBSCRIPTION OR
PURCHASE TITLE $25USD)